Thomas Stephan
Stock Analyst at Stifel
(1.16)
# 3,373
Out of 4,818 analysts
43
Total ratings
35.71%
Success rate
-14.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Hold | $33 → $28 | $14.48 | +93.37% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $3.21 | +24.61% | 7 | Mar 6, 2025 | |
| STAA STAAR Surgical Company | Maintains: Buy | $38 → $20 | $17.40 | +14.94% | 9 | Feb 12, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $12.78 | +40.90% | 3 | Jan 29, 2025 | |
| GKOS Glaukos | Maintains: Buy | $153 → $175 | $92.61 | +88.96% | 8 | Dec 31, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.22 | +63.93% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $93.73 | +6.69% | 4 | May 15, 2024 |
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $14.48
Upside: +93.37%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.21
Upside: +24.61%
STAAR Surgical Company
Feb 12, 2025
Maintains: Buy
Price Target: $38 → $20
Current: $17.40
Upside: +14.94%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $12.78
Upside: +40.90%
Glaukos
Dec 31, 2024
Maintains: Buy
Price Target: $153 → $175
Current: $92.61
Upside: +88.96%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.22
Upside: +63.93%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $93.73
Upside: +6.69%